Adaptive Biotechnologies Corporation
ADPT
$7.10
-$0.31-4.18%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 2.21% | 7.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.21% | 7.51% | |||
| Cost of Revenue | -209.32% | 73.84% | |||
| Gross Profit | 1,543.07% | -71.55% | |||
| SG&A Expenses | 4.82% | -1.05% | |||
| Depreciation & Amortization | 0.00% | 0.94% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.82% | -5.09% | |||
| Operating Income | -3.69% | 18.65% | |||
| Income Before Tax | -5.05% | 30.60% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.05% | 30.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -3.85% | 0.00% | |||
| Net Income | -5.05% | 30.62% | |||
| EBIT | -3.69% | 18.65% | |||
| EBITDA | -4.81% | 20.13% | |||
| EPS Basic | -4.92% | 30.68% | |||
| Normalized Basic EPS | -9.50% | 17.90% | |||
| EPS Diluted | -4.92% | 30.68% | |||
| Normalized Diluted EPS | -9.50% | 17.90% | |||
| Average Basic Shares Outstanding | 0.11% | 0.07% | |||
| Average Diluted Shares Outstanding | 0.11% | 0.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
